Biofeedback in the treatment of heart failure

Cleveland Clinic Journal of Medicine

Volumn 77, Issue SUPPL. 3, 2010, Pages

  McKee, Michael G ^a   Moravec, Christine S ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENERGIC SYSTEM; ARTICLE; CARDIOVASCULAR DISEASE; CHOLINERGIC SYSTEM; HEART FAILURE; HUMAN; PATHOPHYSIOLOGY; PSYCHOPHYSIOLOGY;

BIOFEEDBACK, PSYCHOLOGY; CARDIOVASCULAR DISEASES; HEART FAILURE; HUMANS; PARASYMPATHETIC NERVOUS SYSTEM; SYMPATHETIC NERVOUS SYSTEM;

EID: 77954743777     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.77.s3.10     Document Type: Article

References (33)

1. McKee MG. Biofeedback: an overview in the context of heart-brain medicine. Cleve Clin J Med 2008; 75(suppl 2):S31-S34.
2. Moravec CS. Biofeedback therapy in cardiovascular disease: rationale and research overview. Cleve Clin J Med 2008; 75(suppl 2):S35-S38.
3. Moss D, McGrady A, Davies TC, Wickramasekera I. Handbook of Mind-Body Medicine for Primary Care. London: Sage Publications; 2003.
4. Schwartz MS, Andrasik F. Biofeedback: A Practitioner's Guide. 3rd ed. New York, NY: Guilford Press; 2003.
5. Triposkiadis F, Karayannis G, Giamouzis G, Skoularigis J, Louridas G, Butler J. The sympathetic nervous system in heart failure. J Am Coll Cardiol 2009; 54:1747-1762.
6. Floras JS. Sympathetic nervous system activation in human heart failure. J Am Coll Cardiol 2009; 54:375-385.
7. Binkley PF, Nunziata E, Haas GJ, Nelson SD, Cody RJ. Parasympathetic withdrawal is an integral component of autonomic imbalance in congestive heart failure: demonstration in human subjects and verification in a paced canine model of ventricular failure. J Am Coll Cardiol 1991; 18:464-472.
8. Li M, Zheng C, Sato T, Kawada T, Sugimachi M, Sunugawa K. Vagal nerve stimulation markedly improves long-term survival after chronic heart failure in rats. Circulation 2004; 109:120-124.
9. Schwartz PJ, DeFerrari GM, Sanzo A, et al. Long term vagal stimulation in patients with advanced heart failure: first experience in man. Eur J Heart Failure 2008; 10:884-891.
10. Levine B, Kalman J, Mayer L, Fillit M, Packer M. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure. N Engl J Med 1990; 323:236-241.
11. Mann DL. Inflammatory mediators and the failing heart: past, present and the foreseeable future. Circ Res 2002; 91:988-998.
12. Parish RC, Evans JD. Inflammation in chronic heart failure. Ann Pharmacother 2008; 42:1002-1016.
13. Tracey KJ. The inflammatory reflex. Nature 2002; 420:853-859.
14. Tracey KJ. Reflex control of immunity. Nat Rev Immunol 2009; 9:418-428.
15. Jankowska EA, Ponikowski P, Piepoli MF, Banasiak W, Anker SD, Poole-Wilson PA. Autonomic imbalance and immune activation in chronic heart failure-pathophysiological links. Cardiovasc Res 2006; 70:434-445.
16. Dracup K, Westlake C, Erickson VS, Moser DK, Caldwell ML, Hamilton MA. Perceived control reduces emotional stress in patients with heart failure. J Heart Lung Transplant 2003; 22:90-93.
17. Pischke CR, Weidner G, Elliott-Eller M, Ornish D. Lifestyle changes and clinical profile in coronary heart disease patients with an ejection fraction of ≤ 40% or > 40% in the Multicenter Lifestyle Demonstration Project. Eur J Heart Failure 2007; 9:928-934.
18. Chang BH, Henricks A, Zhao Y, Rothendler JA, LoCastro JS, Slawsky MT. A relaxation response randomized trial on patients with chronic heart failure. J Cardiopulm Rehab 2005; 25:149-157.
19. Yu DSF, Lee DTF, Woo J. Effects of relaxation therapy on psychologic distress and symptom status in older Chinese patients with heart failure. Psychosom Res 2007; 427-437.
20. Curiati JA, Bocchi E, Freire JO, et al. Meditation reduces sympathetic activation and improves the quality of life in elderly patients with optimally treated heart failure: a prospective randomized study. J Altern Complement Med 2005; 11:465-472.
21. Sullivan MJ, Wood L, Terry J, et al. The support, education and research in chronic heart failure study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J 2009; 157:84-90.
22. Weiner P, Waizman J, Magadle R, Berar-Yanay N, Pelled B. The effect of specific inspiratory muscle training on the sensation of dyspnea and exercise tolerance in patients with congestive heart failure. Clin Cardiol 1999; 22:727-732.
23. Bernardi L, Porta C, Spicuzza L, et al. Slow breathing increases arterial baroreflex sensitivity in patients with chronic heart failure. Circulation 2002; 105:143-145.
24. Moser DK, Dracup K, Woo MA, Stevenson LW. Voluntary control of vascular tone by using skin-temperature biofeedback-relaxation in patients with advanced heart failure. Altern Ther Health Med 1997; 3:51-60.
25. Luskin F, Reitz M, Newell K, Quinn TG, Haskell W. A con-trolled pilot study of stress management training of elderly patients with congestive heart failure. Prev Cardiol 2002; 5:168-172.
26. Swanson KS, Gevirtz RN, Brown M, Spira J, Guarneri E, Stoletniy L. The effect of biofeedback on function in patients with heart failure. Appl Psychophysiol Biofeedback 2009; 34:71-91.
27. Razeghi P, Mukhopadhyay M, Myers TJ, et al. Myocardial tumor necrosis factor alpha expression does not correlate with clinical indices of heart failure in patients on left ventricular assist device support. Ann Thorac Surg 2001; 72:2044-2050.
28. Matteo R, Moravec CS. Expression and immunolocalization of annexins IV, V and VI in the failing and non-failing human heart. Cardiovasc Res 2000; 45:961-970.
29. Dash R, Frank K, Carr AN, Moravec CS, Kranias EG. Gender influences on sarcoplasmic reticulum calcium handling in the failing human myocardium. J Mol Cell Cardiol 2001; 33:1345-1353.
30. DiPaola NR, Sweet WE, Stull LB, Francis GS, Moravec CS. Beta-adrenergic receptors and calcium cycling proteins in normal, hypertrophied and failing human hearts: transition from hypertrophy to failure. J Mol Cell Cardiol 2001; 33:1283-1295.
31. Aquila LA, McCarthy PM, Smedira NG, Young JB, Moravec CS. Cytoskeletal structure and recovery in single human cardiac myocytes. J Heart Lung Transplant 2004; 23:954-963.
32. Fedak PWM, Moravec CS, McCarthy PM, et al. Altered expression of disintegrin metalloproteinases and their inhibitor in human dilated cardiomyopathy. Circulation 2006; 113:238-245.
33. Ogletree-Hughes ML, Stull LB, Sweet WE, Smedira NG, McCarthy PM, Moravec CS. Mechanical unloading restores beta adrenergic responsiveness and reverses receptor downregulation in the failing human heart. Circulation 2001; 104:881-886.